Navigation Links
HDMA Statement On House Passage Of Federal Traceability Legislation
Date:6/3/2013

ARLINGTON, Va., June 3, 2013 /PRNewswire-USNewswire/ -- HDMA President and CEO John M. Gray released the following statement on the voice-vote passage of the Safeguarding America's Pharmaceuticals Act of 2013 (H.R. 1919) by the House of Representatives:

"After nearly a decade of working to create a federal traceability standard for pharmaceuticals, HDMA is pleased by the House of Representatives vote today to pass the Safeguarding America's Pharmaceuticals Act of 2013. Eliminating the cumbersome patchwork of state requirements is a bipartisan solution that will offer the clarity the industry needs to ensure medicines are continued to be delivered safely and on time to the patients who need them. HDMA thanks Reps. Bob Latta (R-Ohio), Jim Matheson (D-Utah) for their leadership on this important issue and are hopeful that they will join with their colleagues in the Senate to send federal traceability legislation to President Obama this summer."   

About HDMA
HDMA is the national association representing primary healthcare distributors, the vital link between the nation's pharmaceutical manufacturers and healthcare providers. Each business day, HDMA member companies ensure that nine million prescription medicines and healthcare products are delivered safely and efficiently to more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDMA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation's healthcare system. For more information, visit www.HealthcareDistribution.org.


'/>"/>
SOURCE Healthcare Distribution Management Association
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Statement: Bayer Mourns Passing of Senator Frank Lautenberg
2. CHPA Statement on Alabama Drug Abuse Task Force Report
3. Lilly Statement on Indiana Biosciences Research Institute
4. American Academy of Ophthalmology Issues Statement on Provisions to Pharmaceutical Compounding Quality and Accountability Act
5. PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
6. Statement By Dinesh Thakur Regarding US Governments Case Against Ranbaxy
7. Epizyme, Inc. Files Registration Statement for Proposed Initial Public Offering
8. Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.)
9. Medical Alarm Concepts Files Information Statement and Provides Update on Corporate Activity
10. Joint Statement On The Presidents Budget From The American Society Of Clinical Oncology, Community Oncology Alliance, ION Solutions and The US Oncology Network
11. Receptos Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... , June 24, 2016  American Respiratory Labs (ARL), a ... now able to perform sophisticated lung assessments in patients, homes, thanks ... Inc. Patients are no longer limited to having ... PRO ® , ARL patients like Jeanne R. of ... the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces its ... The PluriQ™ G9™ Gene Editing System is a complete system for ...
Breaking Medicine News(10 mins):